← All tickers

Is MDLN Worth Buying in 2026?

Medline Inc. Class A common stock

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-06-14

Here’s whether Medline Inc. Class A common stock (MDLN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: RSI 48 — healthy momentum range. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-3.61% over 10 days); 3-month momentum negative (-12.3%). Currently 28.0% off its 52-week high. Score: -2/7.

Ready to act on this? 📈 Trade on Webull

MDLN is trading below its 200-day MA (—) — a key warning sign the longer-term trend is under pressure. An RSI of 48.3 sits in the neutral zone — momentum is neither stretched nor exhausted. With ~6 months of trading history, the return since first available bar is -10.7%. The current 28.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 6 months ago → $8,929 today

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 50-day MA ($40.92)
✓Above 13-day MA ($35.44)
!RSI(7) neutral zone (30–70) — currently 71.8
✗Positive return (-12.3%)
!Within 10% of period high (−25.5%)
Period Range $36.61
$32.82 $49.14
RSI (7) 71.8
0 · OversoldOverbought · 100

Key Metrics

Price$36.61
Period Return-12.3%
Period High$49.14
Period Low$32.82
Drawdown−25.5%
MA-13$35.44
MA-50$40.92
RSI (7)71.8
Avg Volume (30d)12.1M
vs. SPYtrailed by 23.2%

Trade MDLN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers